Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events.
Yoshiro MaezawaYusuke EndoSatomi KonoTomohiro OhnoYuumi NakamuraNaoya TeramotoAyano YamaguchiKazuto AonoTakuya MinamizukaHisaya KatoTakahiro IshikawaMasaya KoshizakaMinoru TakemotoToshinori NakayamaKoutaro YokotePublished in: Journal of diabetes investigation (2023)
Psoriasis is a chronic inflammatory skin disease that is associated with obesity and myocardial infarction. Obesity-induced changes in lipid metabolism promote T helper 17 (Th17) cell differentiation, which in turn promotes chronic inflammation. Th17 cells have central roles in many inflammatory diseases, including psoriasis and atherosclerosis; however, whether treatment of obesity attenuates Th17 cells and chronic inflammatory diseases has been unknown. In this study, we found an increase in Th17 cells in a patient with obesity, type 2 diabetes and psoriasis. Furthermore, weight loss with diet and exercise resulted in a decrease in Th17 cells and improvement of psoriasis. This case supports the hypothesis that obesity leads to an increase in Th17 cells and chronic inflammation of the skin and blood vessel walls, thereby promoting psoriasis and atherosclerosis.
Keyphrases
- weight loss
- induced apoptosis
- type diabetes
- oxidative stress
- cell cycle arrest
- metabolic syndrome
- insulin resistance
- bariatric surgery
- cardiovascular events
- cardiovascular disease
- roux en y gastric bypass
- weight gain
- adipose tissue
- cell death
- dendritic cells
- coronary artery disease
- obese patients
- quantum dots
- glycemic control
- gastric bypass
- smoking cessation